Acropolis Investment Management, LLC Pfizer Inc Transaction History

Acropolis Investment Management, LLC

  • $2.08 Billion
  • Q4 2025

A detailed history of Acropolis Investment Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 18,358 shares of PFE stock, worth $460,418. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,358
Previous 17,239 6.49%
Holding current value
$460,418
Previous $439,000 4.78%
% of portfolio
0.02%
Previous 0.02%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 14, 2026
BUY
$24.23 - $27.37 $27,113 - $30,627
1,119 Added 6.49%
18,358 $460,000
Q3 2025

Oct 07, 2025
BUY
$23.29 - $25.88 $80,443 - $89,389
3,454 Added 25.06%
17,239 $439,000
Q2 2025

Jul 14, 2025
SELL
$21.59 - $24.84 $40,653 - $46,773
-1,883 Reduced 12.02%
13,785 $334,000
Q1 2025

Apr 17, 2025
BUY
$25.01 - $27.13 $41,266 - $44,764
1,650 Added 11.77%
15,668 $397,000
Q4 2024

Jan 14, 2025
BUY
$24.8 - $30.19 $7,787 - $9,479
314 Added 2.29%
14,018 $371,000
Q3 2024

Nov 14, 2024
SELL
$27.7 - $31.39 $9,639 - $10,923
-348 Reduced 2.48%
13,704 $396,000
Q2 2024

Jul 16, 2024
BUY
$25.26 - $29.6 $1,641 - $1,924
65 Added 0.46%
14,052 $393,000
Q1 2024

Apr 17, 2024
BUY
$25.89 - $29.73 $7,585 - $8,710
293 Added 2.14%
13,987 $388,000
Q4 2023

Jan 16, 2024
SELL
$26.13 - $33.94 $31,016 - $40,286
-1,187 Reduced 7.98%
13,694 $394,000
Q3 2023

Oct 11, 2023
SELL
$32.09 - $37.51 $75,828 - $88,636
-2,363 Reduced 13.7%
14,881 $493,000
Q2 2023

Jul 13, 2023
SELL
$36.12 - $41.79 $3,864 - $4,471
-107 Reduced 0.62%
17,244 $632,000
Q1 2023

Apr 11, 2023
BUY
$39.39 - $51.28 $49,552 - $64,510
1,258 Added 7.82%
17,351 $707,000
Q4 2022

Jan 11, 2023
BUY
$41.75 - $54.5 $78,030 - $101,860
1,869 Added 13.14%
16,093 $0
Q3 2022

Oct 12, 2022
SELL
$43.76 - $53.42 $3,719 - $4,540
-85 Reduced 0.59%
14,224 $622,000
Q2 2022

Jul 15, 2022
BUY
$46.53 - $55.17 $26,056 - $30,895
560 Added 4.07%
14,309 $750,000
Q1 2022

Apr 08, 2022
BUY
$45.75 - $56.69 $33,168 - $41,100
725 Added 5.57%
13,749 $712,000
Q4 2021

Jan 14, 2022
BUY
$41.32 - $61.25 $11,941 - $17,701
289 Added 2.27%
13,024 $769,000
Q3 2021

Oct 12, 2021
BUY
$39.25 - $50.42 $7,104 - $9,126
181 Added 1.44%
12,735 $511,000
Q2 2021

Jul 16, 2021
BUY
$35.91 - $40.68 $71 - $81
2 Added 0.02%
12,554 $492,000
Q1 2021

Apr 12, 2021
BUY
$33.49 - $37.77 $13,429 - $15,145
401 Added 3.3%
12,552 $455,000
Q4 2020

Jan 13, 2021
BUY
$33.47 - $42.56 $24,633 - $31,324
736 Added 6.45%
12,151 $447,000
Q3 2020

Oct 09, 2020
BUY
$31.75 - $37.25 $82,740 - $97,073
2,606 Added 29.58%
11,415 $419,000
Q2 2020

Jul 15, 2020
BUY
$30.12 - $36.54 $60 - $73
2 Added 0.02%
8,809 $288,000
Q1 2020

Apr 10, 2020
BUY
$27.03 - $38.62 $21,056 - $30,084
779 Added 9.7%
8,807 $287,000
Q4 2019

Jan 14, 2020
BUY
$32.92 - $37.36 $2,008 - $2,278
61 Added 0.77%
8,028 $308,000
Q3 2019

Oct 15, 2019
SELL
$32.49 - $42.13 $5,945 - $7,709
-183 Reduced 2.25%
7,967 $286,000
Q2 2019

Jul 11, 2019
SELL
$36.98 - $41.52 $73,923 - $82,998
-1,999 Reduced 19.7%
8,150 $353,000
Q4 2018

Jan 10, 2019
BUY
$38.47 - $43.86 $13,464 - $15,351
350 Added 3.57%
10,149 $443,000
Q3 2018

Oct 03, 2018
BUY
$34.47 - $41.81 $48,602 - $58,952
1,410 Added 16.81%
9,799 $432,000
Q2 2018

Jul 12, 2018
BUY
$32.98 - $35.16 $2,176 - $2,320
66 Added 0.79%
8,389 $304,000
Q1 2018

Apr 04, 2018
SELL
$31.91 - $37.02 $22,624 - $26,247
-709 Reduced 7.85%
8,323 $295,000
Q4 2017

Jan 11, 2018
BUY
$33.26 - $35.29 $80,289 - $85,190
2,414 Added 36.48%
9,032 $327,000
Q3 2017

Oct 17, 2017
BUY
$31.0 - $34.15 $140,554 - $154,836
4,534 Added 217.56%
6,618 $236,000
Q3 2017

Oct 12, 2017
BUY
$31.0 - $34.15 $64,604 - $71,168
2,084
2,084 $236,000

Others Institutions Holding PFE

# of Institutions
3,372
Shares Held
3.57B
Call Options Held
86.1M
Put Options Held
105M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Acropolis Investment Management, LLC Portfolio

Follow Acropolis Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email